Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes

Luay Alkazmi; Hayder M. Al‐kuraishy; Gaber El‐Saber Batiha; Gomaa Mostafa‐Hedeab; Michel De Waard; Jean‐Marc Sabatier; Saeed Kabrah; ‏Hebatallah M. Saad; Ali I. Al‐Gareeb; Jesus Simal Gandara

doi:10.1007/s40268-022-00397-0

Related publications

Preprint2021

SARS-CoV-2 re-infection risk in Austria

Stefan Pilz, Ali Chakeri, John P A Ioannidis, Lukas Richter, Verena Theiler‐Schwetz, Christian Trummer, Robert Krause, Franz Allerberger

Article2021

SARS‐CoV‐2 re‐infection risk in Austria

Stefan Pilz, Ali Chakeri, John P A Ioannidis, Lukas Richter, Verena Theiler‐Schwetz, Christian Trummer, Robert Krause, Franz Allerberger

Article2021

Perspectives for antivirals to limit SARS-CoV-2 infection (COVID-19)

De Clercq Erik

Article2021

SARS-CoV-2 infection and replication in human gastric organoids

Giovanni Giuseppe Giobbe, Francesco Bonfante, Brendan C. Jones, Onelia Gagliano, Camilla Luni, Elisa Zambaiti, Silvia Perin, Cecilia Laterza, Georg Busslinger, Hannah Stuart, Matteo Pagliari, Alessio Bortolami, Eva Mazzetto, Anna Manfredi, Chiara Colantuono, Lucio Di Filippo, Alessandro Filippo Pellegata, Valentina Panzarin, Nikhil Thapar, Simon Eaton, Davide Cacchiarelli, Hans Clevers, Nicola Elvassore, Paolo De Coppi,

Article2024

Trends of Common Laboratory Biomarkers after SARS-CoV-2 Infection

Tomer David Meirman, Bracha Shapira, Ran D. Balicer, Lior Rokach, Noa Dagan

Journal of Infection

Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes

Discussion(0)

Related publications

SARS-CoV-2 re-infection risk in Austria

SARS‐CoV‐2 re‐infection risk in Austria

Perspectives for antivirals to limit SARS-CoV-2 infection (COVID-19)

SARS-CoV-2 infection and replication in human gastric organoids

Trends of Common Laboratory Biomarkers after SARS-CoV-2 Infection